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FETAL HEMOGLOBIN AND ALPHA 1 MICROGLOBULIN AS  
BIOCHEMICAL MARKERS IN PREDICTING PRE ECLAMPSIA IN 
LATE FIRST TRIMESTER AND EARLY SECOND TRIMESTER OF 
PREGNANCY 
 
AIMS AND OBJECTIVES 
To establish association between high levels of fetal hemoglobin and alpha 1 
microglobulin in maternal plasma and  development of pre eclampsia in 10 to 16 
weeks GA 
MATERIALS AND METHODS 
The present study was undertaken in the Department of Obstetrics and 
Gynaecology, between September 2016 and august 2017. This was a prospective 
cohort study done to establish association between high levels of fetal hemoglobin 
and alpha 1 microglobulin in pregnant women of 10 to 16 weeks of GA and 
subsequent development of preeclampsia in these women.A total of 100 pregnant 
women were included in the study. 
INCLUSION CRITERIA:  
-10 – 16 weeks of pregnancy 
         -Singleton /Multiple pregnancy 
         -Age 20-35 years 
         -Both primi and multigravida 
         -BMI 16-35 
  
EXCLUSION CRITERIA 
-Diabetes 
-Hypertension 
-Renal disease 
-Epilepsy 
-Vascular disorders 
PARAMETERS STUDIED 
                Fetal hemoglobin 
                Alpha 1 microglobulin 
PROCEDURE: 
Hundred pregnant women attending IOG hospital who were willing to 
participate in the study were recruited after getting consent. Blood samples of these 
women were collected and measured using ELISA. They were managed by 
department protocol and followed till delivery. General parameters like age, parity, 
BP, BMI, gestational age, mode of delivery and perinatal outcome were compared 
between both groups. The values of fetal hemoglobin and α1 microglobulin were 
correlated with the development of preeclampsia 
STATISTICAL ANALYSIS: 
Data were collected and included in a data based system and analysed by 
statistician. Parametric data were expressed as mean and standard deviation. It was 
analysed statistically using t-test and non parametric data were expressed as 
percentages and analyzed using chi square. Receiver operator characteristics 
analysis was used to identify the optimal threshold values of fetal hemoglobin and 
α1 microglobulin. Sensitivity, specificity, positive and negative predictive values 
of fetal hemoglobin and alpha 1 microglobulin were profiled by curves. All 
participants were subjected to full history taking and clinical examination. 
            Fetal hemoglobin and alpha 1 microglobulin levels were measured  by 
ELIZA technique. 
 
SUMMARY 
 This prospective cohort study was conducted in the Department of 
Obstetrics and Gynaecology, ISO,KGH, Triplicane, Chennai. One hundred women 
were enrolled in the study. Plasma levels of HbF and α1 microglobulin were 
estimated.  
Findings are summarized as follows: 
 Mean age of women who developed preeclampsia was 26.22. 
  Majority of women were primigravida. 
 Mean  BMI of preeclamptic women was 21.74. 
 Mean arterial pressure was 111.33 mm of Hg in women who developed 
preeclampsia and 88.33 mm of Hg in normal pregnant women. 
 Majority of the women who developed preeclampsia required one or more 
antihypertensives for control of blood pressure in the antenatal period. 
 Induction of preeclamptic women were done at 37 weeks 
 Mean gestational age at delivery was 37 weeks.  
 Vaginal delivery was slightly higher in preeclamptic women. But this was 
not statistically significant. 
 
 
  Mean birth weight of babies born to preeclamptic mother was 2.75kg. 
 Serum levels of fetal hemoglobin and α1 microglobulin were higher in 
preeclamptic women compared with normal women. The difference was 
statistically significant. 
 
CONCLUSION 
From the present study it may be concluded that  
              Higher values of HbF and α1 microglobulin in pregnant women between 
10 to 16 weeks gestational age positively correlates with development of 
preeclampsia in those women. 
 HbF and α1 microglobulin can be used as biomarkers in late first trimester 
and early second trimester of pregnancy for detecting preeclampsia.  
